沙利度胺用于治疗或预防慢性移植物抗宿主病的评估。
Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
作者信息
Flowers Mary E D, Martin Paul J
机构信息
Division of Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., DS-290, PO Box 19024, Seattle, WA 98109-1024, USA.
出版信息
Leuk Lymphoma. 2003 Jul;44(7):1141-6. doi: 10.1080/1042819031000079096.
PMID:12916865
Abstract
During the past 5 years, better understanding of immunomodulatory and anti-angiogenesis properties of thalidomide has increased interest in the use of this agent for a wider variety of clinical applications. This article reviews the clinical evaluation of thalidomide for treatment or prevention of chronic graft-versus-host-disease.
摘要
在过去5年中，对沙利度胺免疫调节和抗血管生成特性的更深入了解，激发了人们对将该药物用于更广泛临床应用的兴趣。本文综述了沙利度胺治疗或预防慢性移植物抗宿主病的临床评估。
相似文献
1
Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.沙利度胺用于治疗或预防慢性移植物抗宿主病的评估。
Leuk Lymphoma. 2003 Jul;44(7):1141-6. doi: 10.1080/1042819031000079096.
2
Current role of thalidomide in cancer treatment.
Curr Opin Oncol. 2000 Nov;12(6):564-73. doi: 10.1097/00001622-200011000-00009.
3
Thalidomide in cancer medicine.沙利度胺在癌症医学中的应用。
Ann Oncol. 2004 Aug;15(8):1151-60. doi: 10.1093/annonc/mdh300.
4
The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.沙利度胺在移植物抗宿主病治疗中的潜在应用——临床与实验室信息综述
Leuk Res. 1990;14(5):395-9. doi: 10.1016/0145-2126(90)90024-4.
5
Review of thalidomide use in the pediatric population.沙利度胺在儿科人群中的应用综述。
J Am Acad Dermatol. 2015 Apr;72(4):703-11. doi: 10.1016/j.jaad.2015.01.002. Epub 2015 Jan 21.
6
Thalidomid: current role in the treatment of non-plasma cell malignancies.沙利度胺：在非浆细胞恶性肿瘤治疗中的当前作用。
J Clin Oncol. 2004 Jun 15;22(12):2477-88. doi: 10.1200/JCO.2004.10.127.
7
[Thalidomide: new uses for an old drug].[沙利度胺：一种老药的新用途]
Ned Tijdschr Geneeskd. 2002 Aug 3;146(31):1438-41.
8
[New indications for thalidomide?].[沙利度胺的新适应症？]
Dtsch Med Wochenschr. 2001 Oct 19;126(42):1178-82. doi: 10.1055/s-2001-17892.
9
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.沙利度胺在血液系统恶性肿瘤治疗中的治疗复兴。
Leukemia. 2005 Sep;19(9):1525-31. doi: 10.1038/sj.leu.2403852.
10
Thalidomide. A new beginning.沙利度胺。一个新的开端。
Cancer Pract. 2000 Mar-Apr;8(2):101-3. doi: 10.1046/j.1523-5394.2000.82009.x.
引用本文的文献
1
A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS).一项安慰剂对照、交叉试验，旨在研究噻托溴铵溴化物或安慰剂联合常规治疗对造血干细胞移植（HSCT）后稳定有症状的闭塞性细支气管炎综合征（BOS）的疗效。
Trials. 2024 Apr 6;25(1):243. doi: 10.1186/s13063-024-08051-7.
2
Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial.糖皮质激素难治/依赖的慢性移植物抗宿主病患者的氢治疗：一项单臂、多中心、开放标签、2 期临床试验。
Front Immunol. 2020 Nov 25;11:598359. doi: 10.3389/fimmu.2020.598359. eCollection 2020.
3
How we treat chronic graft-versus-host disease.我们如何治疗慢性移植物抗宿主病。
Blood. 2015 Jan 22;125(4):606-15. doi: 10.1182/blood-2014-08-551994. Epub 2014 Nov 14.
Zotero 插件